Riskpilot← Back to searchSign inGet full accessÄlvsyssels Vård AB
ABIn liquidationOrg 5591091375Hospital activities · NACE 8610Est. 20170 employees
Revenue 2024
SEK 299K
-76% vs 2023
EBITDA margin
-47.8%
-467% vs 2023
Equity ratio
90.6%
Financial strength
Net profit 2024
SEK -141K
-568% vs 2023
| Revenue | SEK 299K | -76% |
| EBITDA | SEK -143K | -467% |
| Net profit | SEK -141K | -568% |
| Total assets | SEK 71K | -78% |
| Equity | SEK 64K | -69% |
| Employees | 0 | — |
Legal name
Älvsyssels Vård AB
Org number
5591091375
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
19 april 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Konsultverksamhet inom intensiv- och uppvakningsvård. Utbildning inom hjärt och lungräddning samt försäljning av utrustning i samband med hjärt och lungräddning.
Address
Email
urban.norberg@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 526 | 1 682 | 1 166 | 1 252 | 299 |
| Staff expenses | — | — | −847 | −907 | −269 |
| EBITDA | 306 | 126 | 124 | 39 | −143 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 306 | 126 | 124 | 39 | −143 |
| Net financials | −1 | — | −0 | −1 | 2 |
| Profit before tax | 305 | 127 | 123 | 38 | −141 |
| Tax | −65 | −27 | −26 | −8 | — |
| Net profit | 240 | 100 | 98 | 30 | −141 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 728 | 449 | 356 | 329 | 71 |
| Equity | 356 | 178 | 176 | 206 | 64 |
| Long-term debt | 0 | 0 | — | 1 | 1 |
| Short-term debt | 372 | 271 | 181 | 122 | 6 |
| Total debt | 372 | 271 | 181 | 123 | 7 |
EBITDA margin
-47.8%
This company
15.8%
Market median
-403% vs market
20202024
Equity ratio
90.6%
This company
38.2%
Market median
+137% vs market
20202024
Return on equity
-219.5%
This company
18.4%
Market median
-1293% vs market
20202024
Net profit margin
-47.2%
This company
8.1%
Market median
-683% vs market
20202024
Asset turnover
4.21×
This company
1.12×
Market median
+276% vs market
20202024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BA Liquidator | Liquidator | 2025 |
| Former (3) | ||
KA Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
DW Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
ÅJ Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2020 – 2021 | |
| Deputy Board Member | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Älvsyssels Vård AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kia Annika Johansson Karlsson | Chief Executive Officer | 0 companies |
| Dorien Wilhelmus Maria H Janssen | Chief Executive Officer | 0 companies |
| Bengt Arne Urban Mikael Norberg | Liquidator | 0 companies |
| Åke Jöran Knutsson | Chief Executive Officer | 0 companies |
| Frida Angelica Eriksson | Board of Directors | 0 companies |
| Gunnar Olof Sandborg | Deputy Board Member | 0 companies |